NGM

NGM Biopharmaceuticals Stock Price

27.15
0.43 (1.61%)
Upgrade to Real-Time
Afterhours (Closed)
27.15
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.43 1.61% 27.15 19:24:22
Open Price Low Price High Price Close Price Prev Close
26.64 26.22 27.285 27.15 26.72
Bid Price Ask Price Spread News
25.35 27.95 2.60 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,320 240,772 $ 26.73 $ 6,436,327 402,982 9.245 - 32.05
Last Trade Time Type Quantity Stock Price Currency
16:39:43 priorref 333 $ 27.15 USD

NGM Biopharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.02B 74.37M 29.86M $ 103.54M $ - -0.66 -21.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

NGM Biopharmaceuticals News

Date Time Source News Article
2/25/202108:00GlobeNewswire Inc.NGM Bio to Present at the Cowen 41st Annual Health Care..
2/16/202114:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/12/202118:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
2/09/202108:00GlobeNewswire Inc.NGM Bio Announces Upcoming Oral Presentation of Phase 1..
2/03/202116:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
1/12/202116:05GlobeNewswire Inc.NGM Bio Outlines 2021 Strategic Priorities Across Its Three..
1/06/202116:25Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NGM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week29.0729.1525.6226.68316,454-1.92-6.6%
1 Month25.8730.74525.053827.44231,8231.284.95%
3 Months24.9032.0524.3027.82326,3452.259.04%
6 Months18.6532.0514.9324.50232,5188.5045.58%
1 Year18.6032.059.24520.49266,9708.5545.97%
3 Years15.1932.058.5518.89223,33011.9678.74%
5 Years15.1932.058.5518.89223,33011.9678.74%

NGM Biopharmaceuticals Description

NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.
Your Recent History
NASDAQ
NGM
NGM Biopha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210302 02:02:59